Literature DB >> 22406546

Awake fiberoptic intubation and self-positioning in patients at risk of secondary cervical injury: a pilot study.

Michael Joerg Malcharek1, Birgit Rogos, Stefan Watzlawek, Oliver Sorge, Armin Sablotzki, Jochen Gille, C Philip Larson.   

Abstract

BACKGROUND: This study was designed to document the feasibility of self-positioning after awake fiberoptic intubation of the trachea using primarily effective topical anesthesia rather than sedation.
METHODS: We investigated 14 patients (ASA physical status 1 to 3) with a neurosurgical diagnosis of cervical instability or at risk of secondary cervical injury, who were scheduled for awake fiberoptic intubation and self-positioning prone. Topical anesthesia was accomplished using an oropharyngeal spray of lidocaine alone or in combination with a transtracheal injection of lidocaine for awake fiberoptic intubation and self-positioning prone. Patients evidencing anxiolysis were given midazolam 2 to 4 mg, i.v.. We assessed the need for sedation, tolerance of the endotracheal tube, patient comfort, incidence of coughing or gagging, and changes in heart rate, blood pressure, and oxygen saturation. In addition, patients were interviewed on the first postoperative day and asked to categorize the experience of awake intubation and positioning as a positive, neutral, or negative experience, or to have no recall.
RESULTS: Eleven of the 14 patients turned themselves prone after awake fiberoptic intubation. No additional sedation was necessary for accomplishing positioning. Whereas 50% of the patients (7/14) showed mostly slight coughing or gagging during fiberoptic intubation, none of the patients who were positioned awake had coughing or gagging during tube fixation and prone positioning. The technique was unsuccessful in 3 patients. None of the patients viewed this as a negative experience.
CONCLUSIONS: Our study demonstrates that awake fiberoptic intubation and patient self-positioning was feasible in this sample of patients at risk of secondary cervical injury. This technique may extend the opportunity of continuous neurological monitoring in patients with a risk of position-related cervical injury, especially where electrophysiological monitoring is not possible or is unavailable.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22406546     DOI: 10.1097/ANA.0b013e31824da7e5

Source DB:  PubMed          Journal:  J Neurosurg Anesthesiol        ISSN: 0898-4921            Impact factor:   3.956


  7 in total

Review 1.  Fibreoptic intubation in airway management: a review article.

Authors:  Jolin Wong; John Song En Lee; Theodore Gar Ling Wong; Rehana Iqbal; Patrick Wong
Journal:  Singapore Med J       Date:  2018-07-16       Impact factor: 1.858

2.  Emergency Neurological Life Support: Airway, Ventilation, and Sedation.

Authors:  Venkatakrishna Rajajee; Becky Riggs; David B Seder
Journal:  Neurocrit Care       Date:  2017-09       Impact factor: 3.210

3.  Endotracheal intubation: ultrasound-guided versus fiberscope in patients with cervical spine immobilization.

Authors:  Moustafa Abdelaziz Moustafa; Emad A Arida; Ola M Zanaty; Sameh Fathy El-Tamboly
Journal:  J Anesth       Date:  2017-09-21       Impact factor: 2.078

4.  What you need to know about ossification of the posterior longitudinal ligament to optimize cervical spine surgery: A review.

Authors:  Nancy E Epstein
Journal:  Surg Neurol Int       Date:  2014-04-16

5.  GlideScope versus D-blade for tracheal intubation in cervical spine patients: A randomised controlled trial.

Authors:  Dinesh Kumar; Satinder Gombar; Vanita Ahuja; Arvind Malhotra; Shruti Gupta
Journal:  Indian J Anaesth       Date:  2019-07

6.  Airway management in cervical spine injury.

Authors:  Naola Austin; Vijay Krishnamoorthy; Arman Dagal
Journal:  Int J Crit Illn Inj Sci       Date:  2014-01

7.  The need to add motor evoked potential monitoring to somatosensory and electromyographic monitoring in cervical spine surgery.

Authors:  Nancy E Epstein
Journal:  Surg Neurol Int       Date:  2013-10-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.